Zoetis Inc. Q1 2024 10-Q Filing
Ticker: ZTS · Form: 10-Q · Filed: 2024-05-02T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Zoetis Q1 2024 10-Q is in. Check financials vs. last year.
AI Summary
Zoetis Inc. filed its 10-Q for the quarter ending March 31, 2024. The company reported financial results for the first quarter of 2024, comparing them to the same period in 2023. The filing includes details on various financial statement items and hedging activities.
Why It Matters
This filing provides investors with the official financial performance of Zoetis Inc. for the first quarter of 2024, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2024 Q1 — Reporting Period (First quarter of 2024)
- 2023-01-01 to 2023-03-31 — Prior Period (Comparison period for Q1 2024 results)
Key Players & Entities
- Zoetis Inc. (company) — Filer of the 10-Q
- 20240331 (date) — End of the reporting period
- 20240502 (date) — Filing date
- 0001555280 (company) — CIK number for Zoetis Inc.
FAQ
What is the reporting period for this 10-Q filing?
The reporting period is for the quarter ended March 31, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 2, 2024.
What is Zoetis Inc.'s Central Index Key (CIK)?
Zoetis Inc.'s CIK is 0001555280.
What is the SIC code for Zoetis Inc.?
The Standard Industrial Classification (SIC) code for Zoetis Inc. is 2834, Pharmaceutical Preparations.
What types of hedging activities are mentioned in the filing?
The filing mentions Cash Flow Hedging and Net Investment Hedging activities for the periods ending March 31, 2024, and March 31, 2023.
From the Filing
0001555280-24-000249.txt : 20240502 0001555280-24-000249.hdr.sgml : 20240502 20240502122611 ACCESSION NUMBER: 0001555280-24-000249 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 95 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 24906623 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 10-Q 1 zts-20240331.htm 10-Q zts-20240331 false 2024 Q1 0001555280 12/31 0 0 0001555280 2024-01-01 2024-03-31 0001555280 2024-04-26 xbrli:shares iso4217:USD 0001555280 2023-01-01 2023-03-31 iso4217:USD xbrli:shares 0001555280 us-gaap:CashFlowHedgingMember 2024-01-01 2024-03-31 0001555280 us-gaap:CashFlowHedgingMember 2023-01-01 2023-03-31 0001555280 us-gaap:NetInvestmentHedgingMember 2024-01-01 2024-03-31 0001555280 us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-03-31 0001555280 2024-03-31 0001555280 2023-12-31 0001555280 us-gaap:CommonStockMember 2023-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2023-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001555280 us-gaap:RetainedEarningsMember 2023-12-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001555280 us-gaap:NoncontrollingInterestMember 2023-12-31 0001555280 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001555280 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001555280 us-gaap:TreasuryStockCommonMember zts:ShareRepurchaseProgramMember 2024-01-01 2024-03-31 0001555280 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001555280 us-gaap:CommonStockMember 2024-03-31 0001555280 us-gaap:TreasuryStockCommonMember 2024-03-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001555280 us-gaap:RetainedEarningsMember 2024-03-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001555280 us-gaap:NoncontrollingInterestMember 2024-03-31 0001555280 us-gaap:CommonStockMember 2022-12-31 0001555280 us-gaap:TreasuryStockCommonMember 2022-12-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001555280 us-gaap:RetainedEarningsMember 2022-12-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001555280 us-gaap:NoncontrollingInterestMember 2022-12-31 0001555280 2022-12-31 0001555280 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001555280 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001555280 us-gaap:TreasuryStockCommonMember zts:ShareRepurchaseProgramMember 2023-01-01 2023-03-31 0001555280 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001555280 us-gaap:CommonStockMember 2023-03-31 0001555280 us-gaap:TreasuryStockCommonMember 2023-03-31 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001555280 us-gaap:RetainedEarningsMember 2023-03-31 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001555280 us-gaap:NoncontrollingInterestMember 2023-03-31 0001555280 2023-03-31 zts:geographicRegion zts:country 0001555280 us-gaap:ProductMember 2024-03-31 zts:specie zts:productCategory zts:product_category 0001555280 country:US 2024-01-01 2024-03-31 0001555280 country:US 2023-01-01 2023-03-31 0001555280 country:AU 2024-01-01 2024-03-31 0001555280 country:AU 2023-01-01 2023-03-31 0001555280 country:BR 2024